---
title: "Liuzhou Liangmianzhen Co.,Ltd. (600249.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600249.SH.md"
symbol: "600249.SH"
name: "Liuzhou Liangmianzhen Co.,Ltd."
industry: "Personal Care Products"
datetime: "2026-03-13T07:57:01.738Z"
locales:
  - [en](https://longbridge.com/en/quote/600249.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600249.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600249.SH.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/600249.SH.md) | [繁體中文](https://longbridge.com/zh-HK/quote/600249.SH.md)


# Liuzhou Liangmianzhen Co.,Ltd. (600249.SH)

## Company Overview

Liuzhou Liangmianzhen Co., Ltd. produces and sells oral care and personal care products, hotel daily necessities, and pharmaceutical products in China and internationally. It offers toothpaste, toothbrush, mouthwash, laundry detergents, kitchen and bathroom cleaner, body and hair care, travel suit, and other products. The company produces and sells medicines, including tablets, capsules, granules, and raw material, such as potassium, acid, asarum, zinc undecenoate, and paeonol, and other oral solutions.

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Exchange | CN Market |
| Website | [www.lmz.com.cn](https://www.lmz.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-03-13T04:30:12.000Z

**Overall: C (0.49)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 23 / 27 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -3.11% |  |
| Net Profit YoY | -69.76% |  |
| P/B Ratio | 1.45 |  |
| Dividend Ratio | 0.52% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3185798603.32 |  |
| Revenue | 1077487291.11 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.94% | D |
| Profit Margin | 1.91% | C |
| Gross Margin | 14.48% | D |
| Revenue YoY | -3.11% | D |
| Net Profit YoY | -69.76% | E |
| Total Assets YoY | 1.58% | C |
| Net Assets YoY | 0.26% | C |
| Cash Flow Margin | 5235.58% | A |
| OCF YoY | -3.11% | D |
| Turnover | 0.39 | C |
| Gearing Ratio | 20.88% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Liuzhou Liangmianzhen Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-3.11%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-69.76%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.45",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.52%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3185798603.32",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1077487291.11",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.94%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "1.91%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "14.48%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "-3.11%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-69.76%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.58%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.26%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "5235.58%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-3.11%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.39",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "20.88%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 154.80 | 20/27 | 160.15 | 47.90 | 42.90 |
| PB | 1.45 | 2/27 | 1.57 | 1.50 | 1.46 |
| PS (TTM) | 2.96 | 12/27 | 3.18 | 3.03 | 2.93 |
| Dividend Yield | 0.52% | 17/27 | 0.52% | 0.51% | 0.48% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Proya (603605.SH) | A | C | A | B | C | B |
| 02 | FLYCO (603868.SH) | B | D | A | A | C | B |
| 03 | TIANXIN PHARMA (603235.SH) | B | B | C | A | C | B |
| 04 | Marubi (603983.SH) | B | B | B | B | B | B |
| 05 | Runben Biotechnology (603193.SH) | A | B | B | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/600249.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/600249.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/600249.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/600249.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**